Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AVAC is a premier international non-profit organization dedicated to accelerating the ethical development and global delivery of HIV prevention options. Founded in 1995, the organization operates at the intersection of biomedical research, policy advocacy, and community engagement to ensure that HIV prevention tools reach priority populations. AVAC provides critical analysis of the global HIV prevention pipeline, including vaccines, long-acting PrEP, and multi-purpose prevention technologies. By fostering collaborations between researchers, policymakers, and affected communities, AVAC works to translate scientific progress into effective public health programs and holds stakeholders accountable for ending the AIDS epidemic.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AIDS Vaccine Advocacy Coalition.